Liu Hai, M.D.& Ph.D., Professor and Associate Chief Physician of Radiation Oncology. Dr. Liu specializes in radiotherapy and chemotherapy of common malignant tumors, especially in precision radiotherapy. During his studies, he completed the study and training in clinical medicine, imaging medicine and clinical oncology. During his doctoral study, he studied under the guidance of Prof. Zheng Shu with a research focus on the mechanism of DNA damage repair and tumor radiosensitization therapy. He has rich clinical experience in the diagnosis and treatment of common malignant tumors. He made great efforts to apply modern precision radiotherapy technology to tumor treatment, including Intensity-modulated radiation therapy (IMRT), Stereotactic body radiation therapy (SBRT), Volumetric modulated arc therapy (VMAT), etc. He can also skillfully apply a variety of comprehensive treatment methods such as chemotherapy, targeted therapy and immunotherapy.

Intensity-modulated radiotherapy for malignant tumors 

 Stereotactic radiotherapy for malignant tumors

Concurrent radiotherapy and chemotherapy for malignant tumors  

 Immunotherapy for malignant tumors  

 Molecular targeted therapy of malignant tumor

Stereotactic radiotherapy for early lung cancer and various metastatic tumors

Radiotherapy and chemotherapy for common tumors such as advanced lung cancer and esophageal cancer, etc.

Postoperative adjuvant radiotherapy and chemotherapy for breast cancer and urogenital system tumors

Radiotherapy and chemotherapy for common head and neck tumors, such as nasopharyngeal carcinoma, laryngeal cancer, etc.

Member of the Radiotherapy Committee, Zhejiang Medical Doctors Association

Member of the Special Committee of Urological Oncology, Zhejiang Medical Doctors Association

Member of the Special Committee of Esophageal Cancer, Zhejiang Cancer Prevention Alliance

Member of the Anti-cancer Drugs Committee, Zhejiang Anti-cancer Association